116 related articles for article (PubMed ID: 22642421)
1. Synthesis of [DTPA-bis(D-ser)] chelate (DBDSC): an approach for the design of SPECT radiopharmaceuticals based on technetium.
Varshney R; Sethi SK; Hazari PP; Chuttani K; Soni S; Milton MD; Mishra AK
Curr Radiopharm; 2012 Oct; 5(4):348-55. PubMed ID: 22642421
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-DTPA-amino acids conjugate as specific SPECT pharmaceuticals for tumor imaging.
Sinha D; Shukla G; Tiwari AK; Chaturvedi S; Chuttani K; Chandra H; Mishra AK
Chem Biol Drug Des; 2009 Aug; 74(2):159-64. PubMed ID: 19614681
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
[TBL] [Abstract][Full Text] [Related]
6. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
Abiraj K; Mansi R; Tamma ML; Forrer F; Cescato R; Reubi JC; Akyel KG; Maecke HR
Chemistry; 2010 Feb; 16(7):2115-24. PubMed ID: 20066690
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
[TBL] [Abstract][Full Text] [Related]
8. Synthesis,
Wang J; Yang W; Xue J; Zhang Y; Liu Y
J Labelled Comp Radiopharm; 2017 Dec; 60(14):659-665. PubMed ID: 29023951
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biodistribution studies of two novel radiolabeled estrone derivatives.
Enginar H; Unak P; Lambrecht FY; Biber Muftuler FZ; Medine EI
In Vivo; 2008; 22(1):93-100. PubMed ID: 18396789
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of (99m)Tc-DTPA-bis(His) as a potential probe for tumor imaging with SPECT.
Sinha D; Shukla G; Chuttani K; Chandra H; Mishra AK
Cancer Biother Radiopharm; 2009 Oct; 24(5):615-20. PubMed ID: 19877892
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and preclinical investigation of
Shah SQ; Gul-E-Raana
Mol Biol Rep; 2019 Apr; 46(2):1675-1682. PubMed ID: 30680596
[TBL] [Abstract][Full Text] [Related]
12. Solid phase synthesis, radiolabeling and biological evaluation of a (99m) Tc-labeled α(V)β(3) tripeptide (RGD) conjugated to DOTA as a tumor imaging agent.
Varshney R; Hazari PP; Uppal JK; Pal S; Stromberg R; Allard M; Mishra AK
Cancer Biol Ther; 2011 May; 11(10):893-901. PubMed ID: 21372636
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of newly designed phosphonate based bone-seeking agent.
Srivastava P; Tiwari AK; Chadha N; Chuttani K; Mishra AK
Eur J Med Chem; 2013 Jul; 65():12-20. PubMed ID: 23688696
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-Tetraethylenepentamine-Folate--a new 99mTc-based folate derivative for the detection of folate receptor positive tumors: synthesis and biological evaluation.
Panwar P; Shrivastava V; Tandon V; Mishra P; Chuttani K; Sharma RK; Chandra R; Mishra AK
Cancer Biol Ther; 2004 Oct; 3(10):995-1001. PubMed ID: 15467429
[TBL] [Abstract][Full Text] [Related]
15.
Wang J; Ma J; Zhao Q; Yang W; Xue J; Zhang Y; Liu Y
J Labelled Comp Radiopharm; 2018 Apr; 61(4):395-401. PubMed ID: 29388253
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates.
Lu G; Maresca KP; Hillier SM; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
Bioorg Med Chem Lett; 2013 Mar; 23(5):1557-63. PubMed ID: 23333070
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
18. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.
Vera DR; Wallace AM; Hoh CK; Mattrey RF
J Nucl Med; 2001 Jun; 42(6):951-9. PubMed ID: 11390562
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
Trump DP; Mathias CJ; Yang Z; Low PS; Marmion M; Green MA
Nucl Med Biol; 2002 Jul; 29(5):569-73. PubMed ID: 12088727
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and radiolabeling of a new amphiphilic derivative of DTPA.
Aldenhoff YB; Van Kroonenburgh MJ; Koole LH
Nucl Med Biol; 1996 Jul; 23(5):653-6. PubMed ID: 9044688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
